| Patents for C12R 1 - Micro-organisms (92,025) |
|---|
| 03/02/2000 | CA2337905A1 Targeted alphavirus and alphaviral vectors |
| 03/02/2000 | CA2335652A1 Polynucleotide sequences |
| 03/02/2000 | CA2335379A1 Genetic method for the expression of polyproteins in plants |
| 03/01/2000 | EP0982405A2 Recombinant alphavirus vectors |
| 03/01/2000 | EP0982404A1 DNA encoding amorpha-4,11-diene synthase |
| 03/01/2000 | EP0981953A2 Transgenic plants transformed with fumonisin detoxifying enzymes |
| 03/01/2000 | EP0981635A1 Production of mature proteins in plants |
| 03/01/2000 | EP0981631A1 Polypeptides having aminopeptidase activity and nucleic acids encoding same |
| 03/01/2000 | EP0981630A1 Polypeptides having prolyl pipeptidyl aminopeptidase activity and nucleic acids encoding same |
| 03/01/2000 | EP0981619A1 T1/st2-receptor ligand iii |
| 03/01/2000 | EP0981607A1 Modiified arginine deiminase |
| 03/01/2000 | EP0981600A1 Transformed microorganisms with improved properties |
| 03/01/2000 | EP0981548A1 Single-chain antigen-binding proteins capable of glycosylation, production and uses thereof |
| 03/01/2000 | EP0981544A2 Anti-bacterial methods and materials |
| 03/01/2000 | EP0981540A1 A NOVEL STRAIN OF $i(BACILLUS) FOR CONTROLLING PLANT DISEASES AND CORN ROOTWORM |
| 03/01/2000 | EP0769020B1 NEW hIL-4 MUTANT PROTEINS USED AS ANTAGONISTS OR PARTIAL AGONISTS OF HUMAN INTERLEUKIN 4 |
| 03/01/2000 | EP0702564B1 Novel attenuated pseudomonas aeruginosa strains |
| 03/01/2000 | EP0666760B1 VACCINE COMPRISING PART OF CONSTANT REGION OF IgE FOR TREATMENT OF IgE-MEDIATED ALLERGIC REACTIONS |
| 03/01/2000 | CN1246156A Novel bacterial strains and use thereof in fermentation processes for 2-keto-L-gulonic acid production |
| 03/01/2000 | CN1246155A Method for production of dicarboxylic acids |
| 03/01/2000 | CN1246149A Thermostable endo-beta-1,4-glucanase |
| 03/01/2000 | CN1246147A Enzymatic process for preparation of cephalosporanic 7 beta-(4-carboxybutanamide) acid by means of modified enzyme D-aminoacid oxidase of trigonopsis variabilis produced in escherichia coli |
| 03/01/2000 | CN1246145A Method for producing oxide with fermentation process |
| 02/29/2000 | US6031151 Callus-specific promoters |
| 02/29/2000 | US6031150 Genome with homozygous disruption of gene by selectable marker; for studying non-insulin dependent diabetes mellitus and persistent hyperinsulinemic hypoglycemia of infancy |
| 02/29/2000 | US6031079 Amino acid sequence; for screening modulators |
| 02/29/2000 | US6030944 Cyclohexapeptidyl bisamine compounds |
| 02/29/2000 | US6030835 Methods and composition for identifying group a streptococcus |
| 02/29/2000 | US6030833 Genetically engineered cell which includes one or more of a human human leukocyte antigen a, b, c, or g transgene; for organ transplants with immunosuppression of human natural killer cell mediated attack |
| 02/29/2000 | US6030823 For industrial production of d-amino acids from n-acetyl-d-amino acids |
| 02/29/2000 | US6030822 Amino acid sequence; for treating skeletal muscle diseases, alzheimer's disease, or peripheral neuropathies in a mammal with an agonist or antagonist of kinase activity; antidiabetic agents |
| 02/29/2000 | US6030820 Process for producing high-purity erythritol crystal |
| 02/29/2000 | US6030817 Transferring portion of the genome of xanthomonas campestris into a sphingomonas species enabling efficient xanthan gum production |
| 02/29/2000 | US6030812 Fusion proteins comprising multiply mutated interleukin-3 (IL-3) polypeptides and second growth factors |
| 02/29/2000 | US6030798 Method of identifying a lipase for treatment of digestive disorders |
| 02/29/2000 | US6030792 Quantitative immunoassay using capture and detection antibodies against specific amino acid sequences of collagen fragments resulting from collagenase cleavage of type ii collagen |
| 02/29/2000 | US6030784 Method for simultaneous identification of differentially expressed mRNAS and measurement of relative concentrations |
| 02/29/2000 | US6030769 Strains of human immunodeficiency virus; for use as sensitive diagnositic agents and immunogenic compositions |
| 02/29/2000 | US6030626 Method for preparing the fimbrin protein of Haemophilus influenzae |
| 02/29/2000 | US6030625 Bordetella pertussis and Bordetella parapertussis strains |
| 02/29/2000 | US6030617 Use of growth differentiation factor-9 (GDF-9) to inhibit oocyte maturation |
| 02/29/2000 | CA2093928C Monoclonal antibodies for detection and treatment of cancer |
| 02/29/2000 | CA2077753C Purified gp120 composition retaining natural conformation |
| 02/29/2000 | CA2033347C Monoclonal antibodies against leukocyte adhesion receptor beta-chain, methods of producing these antibodies and use therefore |
| 02/29/2000 | CA1340916C Method for enhancing production of secondary metabolites using clustered biosynthetic genes |
| 02/29/2000 | CA1340915C Myeloperoxydase humaine et application therapeutique |
| 02/24/2000 | WO2000010013A2 Composition and methods for exposing antigenic epitopes on cultered microorganism |
| 02/24/2000 | WO2000010009A1 Agarose format for mammalian cell based reporter assays |
| 02/24/2000 | WO2000009761A1 Improved microbial catalyst for desulfurization of fossil fuels |
| 02/24/2000 | WO2000009730A2 Cell type specific gene transfer using retroviral vectors containing antibody-envelope fusion proteins and wild-type envelope fusion proteins |
| 02/24/2000 | WO2000009727A2 Dna shuffling to produce herbicide selective crops |
| 02/24/2000 | WO2000009721A1 Increasing stearate content in soybean oil by expression of acyl-acp thiosterase |
| 02/24/2000 | WO2000009717A1 Nucleotide and/or amino-acid sequence controlling the expression of a xylanase promoter-operator nucleotide sequence |
| 02/24/2000 | WO2000009713A1 Adenoviral vectors encoding erythropoietin and their use in gene therapy |
| 02/24/2000 | WO2000009711A2 ISOLATED AND PURIFIED HUMAN SOLUBLE GUANYLYLCYCLASE α1/β1 (hsGCα1/β1) |
| 02/24/2000 | WO2000009704A1 Gene switch |
| 02/24/2000 | WO2000009702A1 Cold-adapted equine influenza viruses |
| 02/24/2000 | WO2000009697A2 Pesticidal toxins and genes from bacillus laterosporus strains |
| 02/24/2000 | WO2000009695A2 Drug targets in candida albicans |
| 02/24/2000 | WO2000009693A2 Identification of the gene causing the mouse scurfy phenotype and its human ortholog |
| 02/24/2000 | WO2000009691A2 Bpc-1: a secreted brain specific protein expressed and secreted by prostate and bladder cancer cells |
| 02/24/2000 | WO2000009688A1 Novel gene and protein osbh encoded thereby |
| 02/24/2000 | WO2000009687A1 Novel gene and protein gmp30 encoded thereby |
| 02/24/2000 | WO2000009681A2 CONSTRUCTION OF NORMALIZED cDNA LIBRARIES FROM EUCARYOTIC CELLS |
| 02/24/2000 | WO2000009680A1 Methods for purifying non-chromosomal nucleic acid molecules from cells |
| 02/24/2000 | WO2000009679A1 Method for obtaining in vitro recombined polynucleotide sequences, sequence banks and resulting sequences |
| 02/24/2000 | WO2000009671A1 Process for purifying human papillomavirus virus-like particles |
| 02/24/2000 | WO2000009669A1 Human mesencephalon cell lines and methods of use therefor |
| 02/24/2000 | WO2000009668A1 Engraftable human neural stem cells |
| 02/24/2000 | WO2000009666A2 Differentiation of non-insulin producing cells into insulin producing cells by glp-1 or exendin-4 and uses thereof |
| 02/24/2000 | WO2000009654A2 Profiling and cataloging expressed protein tags |
| 02/24/2000 | WO2000009551A1 Human chordin-related proteins and polynucleotides encoding them |
| 02/24/2000 | WO2000009541A1 nrdE |
| 02/24/2000 | WO2000009157A1 Protein delivery system using human papillomavirus virus-like particles |
| 02/24/2000 | WO2000009145A1 Treatment of tumors with oligonucleotides directed to insulin-like growth factor-i receptor |
| 02/24/2000 | WO2000009080A1 Incorporation of exogenous lactic bacteria into the oral microflora |
| 02/24/2000 | WO2000009018A1 Collagen type i and type iii hemostatic compositions for use as a vascular sealant and wound dressing |
| 02/24/2000 | WO2000008924A1 Method of performing transgenesis |
| 02/24/2000 | WO1999065947A3 Monoclonal antibodies directed against the g3bp protein, and uses |
| 02/24/2000 | WO1999058684A3 Compounds from moraxella catarrhalis |
| 02/24/2000 | WO1999051722A3 Recombinant l-n-carbamoylase derived from arthrobacter aurescens, and a method for producing l-amino acids by using the same |
| 02/24/2000 | DE19837015A1 New human soluble guanylate cyclase alpha1/beta1 and the nucleic acid encoding the subunits, useful for producing diagnostic antibodies, and for somatic gene therapy of arteriosclerosis |
| 02/24/2000 | CA2340242A1 Method of performing transgenesis |
| 02/24/2000 | CA2340153A1 Methods for purifying non-chromosomal nucleic acid molecules from cells |
| 02/24/2000 | CA2339858A1 Treatment of tumors with oligonucleotides directed to insulin-like growth factor-i receptor |
| 02/24/2000 | CA2339852A1 Agarose format for mammalian cell based reporter assays |
| 02/24/2000 | CA2339817A1 Profiling and cataloging expressed protein tags |
| 02/24/2000 | CA2339779A1 Adenoviral vectors encoding erythropoietin and their use in gene therapy |
| 02/24/2000 | CA2339579A1 Improved microbial catalyst for desulfurization of fossil fuels |
| 02/24/2000 | CA2339575A1 Collagen type i and type iii hemostatic compositions for use as a vascular sealant and wound dressing |
| 02/24/2000 | CA2339418A1 Human chordin-related proteins and polynucleotides encoding them |
| 02/24/2000 | CA2339414A1 Nucleotide and/or amino-acid sequence controlling the expression of a xylanase promoter-operator nucleotide sequence |
| 02/24/2000 | CA2339409A1 Identification of the gene causing the mouse scurfy phenotype and its human ortholog |
| 02/24/2000 | CA2339337A1 Drug targets in candida albicans |
| 02/24/2000 | CA2339326A1 Differentiation of non-insulin producing cells into insulin producing cells by glp-1 or exendin-4 and uses thereof |
| 02/24/2000 | CA2339304A1 Composition and method of using tumor cells |
| 02/24/2000 | CA2339041A1 Construction of normalized cdna libraries from eucaryotic cells |
| 02/24/2000 | CA2335651A1 Gene switch |
| 02/24/2000 | CA2333914A1 Dna shuffling to produce herbicide selective crops |
| 02/24/2000 | CA2333832A1 Pesticidal toxins and genes from bacillus laterosporus strains |